Structures by: Holczbauer T.
Total: 26
C24H22N2O5,2(CH4O)
C24H22N2O5,2(CH4O)
Organic letters (2011) 13, 20 5416-5419
a=6.02250(10)Å b=19.0267(4)Å c=21.5818(4)Å
α=90.00° β=90.00° γ=90.00°
L-8a.p-Br-benzoic acid 1:0.25 clathrate
C24H22N2O5,0.25(C7H4BrO2)
Organic letters (2011) 13, 20 5416-5419
a=13.505(3)Å b=6.1813(11)Å c=15.804(3)Å
α=90.00° β=93.510(4)° γ=90.00°
(η^5^-3,4-diphenyl-1-(2,4,6-trimethylphenyl)-2,5-bis(trimethylsilyl)-1-silacyclopentadien-1-yl)-tetrahydrofuran-lithium
C35H47LiOSi3
Chem. Commun. (2017)
a=11.8347(3)Å b=19.7159(5)Å c=14.9148(4)Å
α=90° β=91.806(7)° γ=90°
2-((1-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)methylene)hydrazine-1-carbothioamide '
C12H15N3OS
New Journal of Chemistry (2020) 44, 28 12154-12168
a=8.8483(7)Å b=10.5831(7)Å c=13.2516(10)Å
α=90° β=102.518(7)° γ=90°
Chloro-(2-((1-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)methylene)hydrazine-1-carbothioamide)-copper(II)
C12H14ClCuN3OS
New Journal of Chemistry (2020) 44, 28 12154-12168
a=12.3620(7)Å b=9.1718(5)Å c=24.3156(13)Å
α=90° β=90° γ=90°
5,5,11,11-tetrabutyl-1,3,7,9-tetraphenyl-4,5,6,10,11,12-hexahydro-5,11- diazadibenzo[ef,kl]heptalene-5,11-diium-bromide
(C56H66N2),2(Br),1(C5H5N),1.8(C4H8O),[solvent]
CrystEngComm (2018)
a=17.465(3)Å b=15.707(3)Å c=25.981(4)Å
α=90° β=110.398(3)° γ=90°
5,11-dibutyl-1,3,7,9-tetraphenyl-4,5,6,10,11,12-hexahydro-5,11-diazadibenzo[ef,kl]heptalene-5,11-diium dichloride
C48H50N22,(Cl1)2
CrystEngComm (2018)
a=12.4240(8)Å b=23.0450(15)Å c=15.1970(8)Å
α=90° β=99.050(7)° γ=90°
5,5,11,11-tetrabutyl-1,3,7,9-tetraphenyl-4,5,6,10,11,12-hexahydro-5,11- diazadibenzo[ef,kl]heptalene-5,11-diium-bromide
C56H66N22,(Br)2,3(C4H8O),[solvent]
CrystEngComm (2018)
a=22.071(3)Å b=25.991(3)Å c=28.554(4)Å
α=90° β=90° γ=90°
5,5,11,11-tetrabutyl-1,3,7,9-tetraphenyl-4,5,6,10,11,12-hexahydro-5,11- diazadibenzo[ef,kl]heptalene-5,11-diium-bromide
C56H66N22,(Br)2,4(C4H8O),[solvent]
CrystEngComm (2018)
a=24.343(3)Å b=15.987(4)Å c=17.571(5)Å
α=90° β=90° γ=90°
N-((6-butyl-2,4,8,10-tetraphenyl-6,7-dihydro-5H-dibenzo[c,e]azepin-1-yl)methyl)-N-ethylbutan-1-amine
C48H48N2
CrystEngComm (2018)
a=15.0148(17)Å b=9.6841(11)Å c=25.874(3)Å
α=90° β=100.421(3)° γ=90°
5,11-dibutyl-1,3,7,9-tetraphenyl-4,5,6,10,11,12-hexahydro-5,11-diazadibenzo[ef,kl]heptalene
C48H48N2
CrystEngComm (2018)
a=12.2542(11)Å b=12.3204(11)Å c=12.4610(11)Å
α=91.981(7)° β=106.699(7)° γ=93.107(7)°
Squaramide based cinchona catalyst
C31H32N4O3
RSC Adv. (2015)
a=8.7790(2)Å b=11.6400(2)Å c=26.194(1)Å
α=90° β=90° γ=90°
3-Ethoxycarbonyl-2-phenyl-1,5-dihydro-4,1-benzothiazepine
C18H17NO2S
CrystEngComm (2010) 12, 6 1712
a=5.905(2)Å b=7.947(4)Å c=16.797(9)Å
α=90.00° β=97.611(15)° γ=90.00°
(R*)-3-Ethoxycarbonyl-2-phenyl-3,5-dihydro-4,1-benzothiazepine
C18H17NO2S
CrystEngComm (2010) 12, 6 1712
a=8.5761(11)Å b=9.7540(11)Å c=10.7880(14)Å
α=65.345(3)° β=73.471(3)° γ=72.509(3)°
3-Ethoxycarbonyl-2-(4-chlorophenyl)-1,5-dihydro-4,1- benzothiazepine
C19H19NO2S
CrystEngComm (2010) 12, 6 1712
a=7.75740(10)Å b=11.3316(2)Å c=17.9221(3)Å
α=90.00° β=90.00° γ=90.00°
(R*)-3-Ethoxycarbonyl-2-(4-chlorophenyl)-3,5-dihydro-4,1- benzothiazepine
C19H19NO2S
CrystEngComm (2010) 12, 6 1712
a=12.9550(4)Å b=7.1696(2)Å c=18.6157(8)Å
α=90.00° β=109.082(2)° γ=90.00°
3-Ethoxycarbonyl-2-(4-methylphenyl)-1,5-dihydro-4,1- benzothiazepine
C18H16ClNO2S
CrystEngComm (2010) 12, 6 1712
a=8.005(4)Å b=10.923(3)Å c=18.797(7)Å
α=90.00° β=90.00° γ=90.00°
(R*)-3-Ethoxycarbonyl-2-(4-methylphenyl)-3,5-dihydro-4,1- benzothiazepine
C18H16ClNO2S
CrystEngComm (2010) 12, 6 1712
a=12.699(2)Å b=7.2028(9)Å c=18.542(3)Å
α=90.00° β=108.578(6)° γ=90.00°
2-Ethoxycarbonyl-3-(4-chlorophenyl)-4,5-dihydro-7,8-dimethoxy- 1,4-benzothiazepine
C20H20ClNO4S
CrystEngComm (2010) 12, 6 1712
a=15.2508(4)Å b=9.1719(3)Å c=14.8923(4)Å
α=90.00° β=115.920(2)° γ=90.00°
C39H32Au2Cl2OP2,0.8(C7H8),0.2(CH2Cl2)
C39H32Au2Cl2OP2,0.8(C7H8),0.2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 31 12569-12575
a=12.1273(9)Å b=21.3275(13)Å c=15.5941(11)Å
α=90° β=101.076(2)° γ=90°
2(C78H62.53Au2.47O2.53P4),C7H8,2(NO3)
2(C78H62.53Au2.47O2.53P4),C7H8,2(NO3)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 31 12569-12575
a=12.6109(18)Å b=15.351(2)Å c=22.690(3)Å
α=90.421(3)° β=97.725(3)° γ=103.650(3)°
(11<i>bS</i>)-<i>N</i>-[(2<i>S</i>,4<i>S</i>)-4-(Diphenylphosphanyl)pentan-2-yl]-<i>N</i>-methyldinaphtho[2,1-<i>d</i>:1',2'-<i>f</i>][1,3,2]dioxaphosphepin-4-amine
C38H35NO2P2
Acta Crystallographica Section C (2017) 73, 8
a=11.7931(5)Å b=10.4209(5)Å c=14.0792(6)Å
α=90° β=111.0806(10)° γ=90°
Diaquatris(1-ethyl-1<i>H</i>-imidazole-κ<i>N</i>^3^)(sulfato-κ<i>O</i>)nickel(II)
C15H28N6NiO6S
Acta Crystallographica Section E (2016) 72, 3 374-377
a=12.0252(13)Å b=14.3481(15)Å c=15.3502(11)Å
α=90° β=128.980(5)° γ=90°
Dichloridobis(2-methoxydibenzo[c,e][1,2]oxaphosphorine-κ<i>P</i>)platinum(II) trichloromethane solvate
C26H20Cl2O4P2Pt,CHCl3
Acta Crystallographica Section E (2009) 65, 3 m347-m348
a=10.186(3)Å b=13.020(5)Å c=13.510(5)Å
α=62.402(11)° β=83.128(12)° γ=67.456(11)°
1-(4-methoxyphenyl)-2,3-diphenylpentaleno[1,2-a]biphenylene
C37H24O
The Journal of organic chemistry (2020)
a=10.2162(16)Å b=14.533(3)Å c=16.867(3)Å
α=90° β=97.256(7)° γ=90°
6-Methyl-4H-pyrido[1,2-a]pyrimidin-4-one
C9H8N2O1
Journal of Organic Chemistry (2011) 76, 696-699
a=3.883(2)Å b=13.708(8)Å c=6.933(4)Å
α=90.00° β=96.545(12)° γ=90.00°